Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 10, 2015, Pages 2240-2250

  Du, Ze Peng ^a,b   Wu, Bing Li ^a   Xie, Yang Min ^a   Zhang, Ying Li ^a   Liao, Lian Di ^a   Zhou, Fei ^a   Xie, Jian Jun ^a   Zeng, Fa Min ^a   Xu, Xiu E ^a   Fang, Wang Kai ^a   Li, En Min ^a   Xu, Li Yan ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU CENTRAL HOSPITAL   (China)

Author keywords

Esophageal squamous cell carcinoma; Lipocalin 2; Migration and invasion of cancer cells; Positive feedback

Indexed keywords

BETA ACTIN; COFILIN; F ACTIN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; ACTIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MAPK1 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; CELL MOTION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ACTINS; ACUTE-PHASE PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; ESOPHAGEAL NEOPLASMS; HUMANS; LIPOCALINS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 84938125696     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.07.007     Document Type: Article

References (36)

1. Flower D.R. The lipocalin protein family: structure and function. Biochem. J. 1996, 318:1-14.
2. Kjeldsen L., Johnsen A.H., Sengeløv H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993, 268:10425-10432.
3. Flower D.R. Experimentally determined lipocalin structures. Biochim. Biophys. Acta 2000, 1482:46-56.
4. Yan L., Borregaard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 2001, 276:37258-37265.
5. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005, 579:773-777.
6. Yang J., Goetz D., Li J.Y., Wang W., Mori K., Setlik D., Du T., Erdjument-Bromage H., Tempst P., Strong R., Barasch J. An iron delivery pathway mediated by a lipocalin. Mol. Cell 2002, 10:1045-1056.
7. Paragas N., Qiu A., Hollmen M., Nickolas T.L., Devarajan P., Barasch J. NGAL-siderocalin in kidney disease. Biochim. Biophys. Acta 2012, 1823:1451-1458.
8. Wenners A.S., Mehta K., Loibl S., Park H., Mueller B., Arnold N., Hamann S., Weimer J., Ataseven B., Darb-Esfahani S., Schem C., Mundhenke C., Khandan F., Thomssen C., Jonat W., Holzhausen H.J., von Minckwitz G., Denkert C., Bauer M. Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS One 2012, 7:e45826.
9. Yang J., Bielenberg D.R., Rodig S.J., Doiron R., Clifton M.C., Kung A.L., Strong R.K., Zurakowski D., Moses M.A. Lipocalin 2 promotes breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3913-3918.
10. Hu L., Hittelman W., Lu T., Ji P., Arlinghaus R., Shmulevich I., Hamilton S.R., Zhang W. NGAL decreases E-cadherin mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab. Investig. 2009, 89:531-548.
11. Martí J., Fuster J., Solà A.M., Hotter G., Molina R., Pelegrina A., Ferrer J., Deulofeu R., Fondevila C., García-Valdecasas J.C. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer. World J. Surg. 2013, 37:1103-1109.
12. Tong Z., Kunnumakkara A.B., Wang H., Matsuo Y., Diagaradjane P., Harikumar K.B., Ramachandran V., Sung B., Chakraborty A., Bresalier R.S., Logsdon C., Aggarwal B.B., Krishnan S., Guha S. Neutrophil gelatinase-associated lipocalin: a novel suppress or of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008, 68:6100-6108.
13. Lim R., Ahmed N., Borregaard N., Riley C., Wafai R., Thompson E.W., Quinn M.A., Rice G.E. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int. J. Cancer 2007, 120:2426-2434.
14. Iannetti A., Pacifico F., Acquaviva R., Lavorgna A., Crescenzi E., Vascotto C., Tell G., Salzano A.M., Scaloni A., Vuttariello E., Chiappetta G., Formisano S., Leonardi A. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14058-14063.
15. Mohammed M.A., Seleim M.F., Abdalla M.S., Sharada H.M., Abdel Wahab A.H. Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer. BMC Urol. 2013, 13:25.
16. Carlo A.D.I. Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors. Oncol. Lett. 2013, 5:1677-1681.
17. Du Z.P., Yuan H.M., Wu B.L., Chang J.X., Lv Z., Shen J., Wu J.Y., Chen H.B., Li E.M., Xu L.Y. Neutrophil gelatinase-associated lipocalin in gastric carcinoma cells and its induction by TPA are controlled by C/EBPβ. Biochem. Cell Biol. 2011, 89:314-324.
18. Liu M.F., Jin T., Shen J.H., Shen Z.Y., Zheng Z.C., Zhang Z.L., Xu L.Y., Li E.M., Xu H.X. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis. J. Neurooncol. 2011, 104:119-127.
19. Xu L.Y., Li E.M., Xiong H.Q., Cai W.J., Shen Z.Y. Study of neutrophil gelatinase-associated lipocalin (NGAL) gene overexpression in the progress of malignant transformation of human immortalized esophageal epithelial cell. Prog. Biochem. Biophys. 2001, 28:839-843.
20. Zhang H., Xu L., Xiao D., Xie J., Zeng H., Wang Z., Zhang X., Niu Y., Shen Z., Shen J., Wu X., Li E. Up regulation of neutrophil gelatinase associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J. Clin. Pathol. 2007, 60:555-561.
21. Du Z.P., Lv Z., Wu B.L., Wu Z.Y., Shen J.H., Wu J.Y., Xu X.E., Huang Q., Shen J., Chen H.B., Li E.M., Xu L.Y. Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma. J. Clin. Pathol. 2011, 64:69-74.
22. Hanai J., Mammoto T., Seth P., Mori K., Karumanchi S.A., Barasch J., Sukhatme V.P. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J. Biol. Chem. 2005, 280:13641-13647.
23. Lee E.K., Kim H.J., Lee K.J., Lee H.J., Lee J.S., Kim D.G., Hong S.W., Yoon Y., Kim J.S. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling. Int. J. Oncol. 2011, 38:325-333.
24. Shen Z., Shen J., Cai W., Chen J., Zeng Y. Malignant transformation of the immortalized esophageal epithelial cells. Zhonghua Zhong Liu Za Zhi 2002, 24:107-109.
25. Xie J.J., Xu L.Y., Wu J.Y., Shen Z.Y., Zhao Q., Du Z.P., Lv Z., Gu W., Pan F., Xu X.E., Xie D., Li E.M. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am. J. Pathol. 2010, 176:939-951.
26. Leng X., Ding T., Lin H., Wang Y., Hu L., Hu J., Feig B., Zhang W., Pusztai L., Symmans W.F., Wu Y., Arlinghaus R.B. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 2009, 69:8579-8584.
27. Pawlak G., Helfman D.M. Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol. Biol. Cell 2002, 13:336-347.
28. Klein R.M., Spofford L.S., Abel E.V., Ortiz A., Aplin A.E. B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization. Mol. Biol. Cell 2008, 19:498-508.
29. Mizuno K. Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation. Cell. Signal. 2013, 25:457-469.
30. Darmellah A., Rayah A., Auger R., Cuif M.H., Prigent M., Arpin M., Alcover A., Delarasse C., Kanellopoulos J.M. Ezrin/radixin/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein. J. Biol. Chem. 2012, 287:34583-34595.
31. Parisiadou L., Xie C., Cho H.J., Lin X., Gu X.L., Long C.X., Lobbestael E., Baekelandt V., Taymans J.M., Sun L., Cai H. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 2009, 29:13971-13980.
32. Li Y.Y., Zhou C.X., Gao Y. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway. Biochem. Biophys. Res. Commun. 2014, 452:490-496.
33. Pullikuth A.K., Catling A.D. Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell. Signal. 2007, 19:1621-1632.
34. Wabnitz G.H., Nebl G., Klemke M., Schröder A.J., Samstag Y. Phosphatidylinositol 3-kinase functions as a Ras effector in the signaling cascade that regulates dephosphorylation of the actin-remodeling protein cofilin after costimulation of untransformed human T lymphocytes. J. Immunol. 2006, 176:1668-1674.
35. Fang W.K., Xu L.Y., Lu X.F., Liao L.D., Cai W.J., Shen Z.Y., Li E.M. A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells. Biochem. J. 2007, 403:297-303.
36. Deng Y.Z., Chen P.P., Wang Y., Yin D., Koeffler H.P., Li B., Tong X.J., Xie D. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J. Biol. Chem. 2007, 282:36571-36581.